Next Quarterly Earnings
Tuesday, August 4, 2026
CW 32
Pre-Market
In 30 days
Incyte, a US-based biopharmaceutical company, is dedicated to the discovery, development, and commercialization of innovative therapeutics. With a strong focus on oncology, inflammation, and autoimmune diseases, Incyte aims to improve the lives of patients globally. The company drives medical progress through targeted research and development, striving to provide much-needed treatment solutions.